Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Quisqualis indica, also known as Chinese honeysuckle or Rangoon creeper, is a traditional medicinal plant used for gastrointestinal issues and lower urinary tract symptoms [PMID:36277358, PMID:36629062].
Contexte
Quisqualis indica L. (Combretaceae family) is a tropical Asian climber used in Traditional Chinese Medicine [PMID:36277358, PMID:38191129].
Usages traditionnels
Traditional uses include treating gastrointestinal discomfort such as stomach pain, constipation, and digestive problems [PMID:36277358, PMID:32793460, PMID:28943529]. It is also used in Chinese Medicine for peptic ulcers, diabetes, inflammation, colds with fever, headaches, and sore throats [PMID:39554608], and is noted for anthelminthic effects and use in treating cancer-related syndromes [PMID:25701753].
Composés actifs
Identified compounds include the alkaloid trigonelline [PMID:40120340, PMID:15719678], quinoline-4-carbonitrile (QCN) [PMID:31264476], and 25-O-acetyl-23,24-dihydro-cucurbitacin F [PMID:25701753, PMID:18202018]. The plant also contains phenols, flavonoids [PMID:30184413], anthocyanins (specifically cyanidin 3-O-glucoside) [PMID:34583599], and various volatile components including fatty acids, aldehydes, and alcohols [PMID:38191129].
Mécanisme d'action
In the treatment of benign prostatic hyperplasia (BPH), a standardized seed extract (HU-033) acts as an antagonist to α1A- and α1D-adrenergic receptors and inhibits the protein expression of androgen and estrogen receptor alpha [PMID:31915646]. It also reduces the expression of androgen receptor (AR) and prostate specific antigen (PSA) [PMID:28943529]. Additionally, floral extracts exhibit anti-inflammatory and antioxidant activities [PMID:31264476].
Preuves cliniques
Preuve BLower Urinary Tract Symptoms (LUTS)
In a randomized, double-blind, placebo-controlled trial of 135 men, both low-dose (1,000 mg) and high-dose (2,000 mg) Quisqualis indica significantly improved total International Prostate Symptom Score (IPSS) at 6 and 12 weeks compared to placebo [PMID:36629062].
Preuve DBenign Prostatic Hyperplasia (BPH)
In rat models, Quisqualis indica extract ameliorated low urinary tract symptoms and reduced prostate weight, serum testosterone, and DHT concentration [PMID:32793460, PMID:28943529].
Preuve DExperimental Esophagitis
Ethanolic flower extract was investigated for its role against esophagitis in albino Wistar rats via free radical scavenging [PMID:30184413].
Sécurité et effets indésirables
A 13-week repeated oral dose toxicity study in rats (up to 2000 mg/kg/day) showed no treatment-related adverse clinical signs, significant decrement in body weight, or histopathological findings [PMID:36277358]. However, a case of photoallergic contact dermatitis caused by Quisqualis indica has been reported [PMID:27040881].
Interactions médicamenteuses
In vitro studies showed that Quisqualis indica significantly enhanced the activity of the antibiotic novobiocin against Acinetobacter baumannii [PMID:22536985].
Posologie et administration
In a clinical trial for LUTS, doses used were 1,000 mg and 2,000 mg [PMID:36629062]. No PubMed data available. Consult a healthcare provider.
Synthèse des preuves
Evidence consists of one clinical RCT for LUTS (Level B), several animal and in vitro studies for BPH and esophagitis (Level D), and toxicological assessments in rats (Level D).
Sources PubMed
1.PMID: 39554608 (2024) — A comprehensive review on Chinese honeysuckle (Qusqualis indica): A Traditional Chinese plant. · Toxicology reports
2.PMID: 36277358 (2022) — Repeated oral dose toxicity and genotoxicity of a standardized Quisqualis indica extract. · Toxicological research
4.PMID: 38191129 (2024) — Origin differentiation based on volatile constituents of genuine medicinal materials Quisqualis indica L. via HS-GC-MS, response surface methodology, and chemometrics. · Phytochemical analysis : PCA
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
— Quisqualis indica extract for men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled trial.
· Investigative and clinical urology
6.PMID: 31264476 (2021) — A quinoline alkaloid rich Quisqualis indica floral extract enhances the bioactivity. · Natural product research
7.PMID: 30184413 (2017) — Effect of ethanolic extract of Quisqualis indica L. flower on experimental esophagitis in albino Wistar rats. · Indian journal of experimental biology
9.PMID: 30159538 (2018) — Light induces petal color change in Quisqualis indica (Combretaceae). · Plant diversity
10.PMID: 27491031 (2016) — One-pot biogenic fabrication of silver nanocrystals using Quisqualis indica: Effectiveness on malaria and Zika virus mosquito vectors, and impact on non-target aquatic organisms. · Journal of photochemistry and photobiology. B, Biology
11.PMID: 40120340 (2025) — Combination of ultrasound and supercritical carbon dioxide extraction for trigonelline production from Quisqualis indica. · Ultrasonics sonochemistry
12.PMID: 29156527 (2018) — Synthesis and characterization of copper nanoparticles stabilized with Quisqualis indica extract: Evaluation of its cytotoxicity and apoptosis in B16F10 melanoma cells. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
13.PMID: 27072926 (2016) — Pollinator responses to floral colour change, nectar, and scent promote reproductive fitness in Quisqualis indica (Combretaceae). · Scientific reports
15.PMID: 15719678 (2004) — [IE-HPLC analysis of trigonelline in Fructus Quisqualis]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
16.PMID: 26766870 (2016) — Enhanced antimicrobial activity of silver nanoparticles-Lonicera Japonica Thunb combo. · IET nanobiotechnology
17.PMID: 30964041 (2019) — Sustainable green synthesis of silver nanoparticles by using Rangoon creeper leaves extract and their spectral analysis and anti-bacterial studies. · IET nanobiotechnology
18.PMID: 34583599 (2023) — Temporal accumulation of pigments during colour transformation from white to red in Combretum indicum (L.) DeFilipps (syn. Quisqualis indica L.) flowers. · Natural product research
19.PMID: 30772796 (2019) — Antioxidant activity of an ethnobotanically important plant Quisqualis indica Linn. · Pakistan journal of pharmaceutical sciences
20.PMID: 31915646 (2019) — Standardized Seed Extract of Quisqualis indica (HU-033) Attenuates Testosterone Propionate-Induced Benign Prostatic Hyperplasia via α1-Adrenergic Receptors and Androgen/Estrogen Signaling. · Preventive nutrition and food science
21.PMID: 13051885 (1953) — [Study of the siliceous hairs of Quisqualis indica]. · Comptes rendus hebdomadaires des seances de l'Academie des sciences
22.PMID: 41330099 (2025) — Microbial-viral synergy in Eisenia fetida gut supports earthworm survival, detoxification, and functional resilience. · The Science of the total environment
23.PMID: 27959441 (2017) — Protective effects of Cambodian medicinal plants on tert‑butyl hydroperoxide‑induced hepatotoxicity via Nrf2‑mediated heme oxygenase‑1. · Molecular medicine reports
24.PMID: 22536985 (2012) — Thai ethnomedicinal plants as resistant modifying agents for combating Acinetobacter baumannii infections. · BMC complementary and alternative medicine
25.PMID: 25701753 (2015) — 25-O-acetyl-23,24-dihydro-cucurbitacin F induces cell cycle G2/M arrest and apoptosis in human soft tissue sarcoma cells. · Journal of ethnopharmacology
26.PMID: 32807192 (2020) — An ethnoveterinary study on medicinal plants used by the Buyi people in Southwest Guizhou, China. · Journal of ethnobiology and ethnomedicine
27.PMID: 11267752 (2001) — Screening of the anticoccidial effects of herb extracts against Eimeria tenella. · Veterinary parasitology
28.PMID: 18202018 (2008) — Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese medicine and Chinese materia medica with activity against tumor cells. · Molecular cancer therapeutics
29.PMID: 26382959 (2016) — Assessment of Air Pollution Tolerance Index of some plants to develop vertical gardens near street canyons of a polluted tropical city. · Ecotoxicology and environmental safety
30.PMID: 15546639 (2005) — Dust accumulation and leaf pigment content in vegetation near the national highway at Sambalpur, Orissa, India. · Ecotoxicology and environmental safety